From October 1, 2023 to December 31, 2023, the company has repurchased 20,000 shares, representing 0.02% for CNY 1.07 million. With this, the company has completed the repurchase of 29,829 shares, representing 0.02% for CNY 1.59 million under the buyback announced on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.02 CNY | -0.99% | -5.32% | -9.03% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.03% | 966M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.